Paliwal Life Science India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.70 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.35 M
- Revenue Growth -50.92%
- Profit Growth -18.37%
- Ebitda -12.16%
- Net Worth 57.22%
- Total Assets 5.44%
About Paliwal Life Science India
Paliwal Life Science India Private Limited (PLSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 March 2018 (Six years and 11 months 7 days old ). Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹1.35 M.
Ravi Singh, Reeta Singh, Neha Singh, and One other member serve as directors at the Company.
Company Details
-
Location
Varanasi, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85320UP2018PTC101602
-
Company No.
101602
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Mar 2018
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Paliwal Life Science India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Singh
|
Director | 05-Mar-2018 | Current |
|
Reeta Singh
|
Director | 05-Mar-2018 | Current |
|
Neha Singh
|
Director | 05-Mar-2018 | Current |
|
Shradha Sharma
|
Director | 17-Nov-2021 | Current |
Financial Performance of Paliwal Life Science India.
Paliwal Life Science India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.92% decrease. The company also saw a substantial fall in profitability, with a 18.37% decrease in profit. The company's net worth Soared by an impressive increase of 57.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paliwal Life Science India?
Unlock access to Paliwal Life Science India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Ananataya Infra Projects Private LimitedRavi Singh is a mutual person
-
Vmr Ecstasy Private Limited
Ravi Singh and Neha Singh are mutual person
Charges (Loans)
₹1.35 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2021 | Hdfc Bank Limited | ₹0.45 M | Open |
| 03 Jun 2021 | Hdfc Bank Limited | ₹0.90 M | Open |
How Many Employees Work at Paliwal Life Science India?
Paliwal Life Science India has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paliwal Life Science India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paliwal Life Science India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.